↧
Image may be NSFW.
Clik here to view.
Clik here to view.
India vs Big Pharma: Bayer loses compulsory licencing verdict
Compulsory licences are here to stay. The Intellectual Property Appellate Board (IPAB) on Monday upheld the country’s first compulsory licence to the Hyderabad based NATCO Pharma for Bayer’s cancer...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
‘Compulsory licence verdict a triumph for humanity’
In what has been billed as landmark ruling the Intellectual Property Appellate Board upheld the country’s first compulsory licence to NATCO Pharma for Bayer’s cancer drug Nexavar recently. In layman...
View Article